TEM: Q2 2026 delivered 22% revenue growth, net income turnaround, and major MRD expansion via acquisitionQuartr·2 hours agoPSNL+4.69%TEM+6.59%
Median Technologies partners with Canon’s Olea Medical to commercialize eyonis LCS lung cancer screening softwarePUBT·6 hours agoCAJPY+0.81%TEM+6.59%
Dear Tempus AI Stock Fans, Mark Your Calendars for July 30Barchart Option·9 hours agoTEM+6.59%TEMT+12.79%
The Fringes of Wall Street: How Small-Cap Innovators and Niche Bets Are Navigating 2026Global Report·13 hours agoCERT-3.83%BLNK+4.23%
13:42 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWDprnewswire·1 day ago, 12:42 PMFNWD+0.27%BLFS+0.44%
Benzinga Bulls and Bears: IBM, Super Micro, Teslabenzinga_article·Jul 25 at 07:00 AMTSL+3.97%XE+11.66%
Tempus AI (TEM) Expected to Announce Earnings on ThursdayMarket Beat·Jul 23 at 04:56 AMTEM+6.59%TEMT+12.79%
Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision MedicineUnusual Whales·Jul 22 at 07:37 AMTEM+6.59%TEMT+12.79%
Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoringbenzinga_article·Jul 21 at 01:52 PMTEM+6.59%PSNL+4.69%
13:54 ET$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Personalis, Inc. (NASDAQ: PSNL)prnewswire·Jul 21 at 12:55 PMPSNL+4.69%TEM+6.59%
